Owner Genencor International, Inc.

Inventors Van Kimmenade, Anita; Lad, Raj; Estell, David A.; Kolkman, Marc; Collier, Katherine D.; Schmidt, Brian; De Nobel, Hans; Miller, Jeffrey V.; Ganshaw, Grant C.; Power, Scott D.; Murray, Christopher J.; Vogtentanz, Gudrun; Day, Anthony

Agent Houlihan2

Pub. Number AU-B-2006246425

PCT Pub. Number WO2006/121610

Priority 60/678,601 05.05.05 US

Parent 2004288698

Filing date 25 April 2006

Wipo publication date 16 November 2006

Acceptance publication date 22 March 2012

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 8/64 (2006.01) Cosmetics or similar toilet preparations

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 9/99 (2006.01) Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora